Found 0 matching trials
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia PHASE1 This study in patients with schizophrenia is designed to provide preliminar...
Show More Location
Clinical Research Institute
Learn More & Join Trial
Standard Comprehensive Intervention to Treat First-episode Schizophrenia NA Schizophrenia is not a curable but a treatable disease by antipsychotics. K...
Show More Location
Beijing Anding Hospital
Learn More & Join Trial
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder PHASE3 To compare changes in body mass index (BMI) Z-score following treatment wit...
Show More Location
Alkermes Investigator Site
Learn More & Join Trial
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846) PHASE3 The primary features of schizophrenia and schizoaffective disorder are posi...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder PHASE3 The efficacy and safety of the extended treatment to patients with most rec...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
An Expanded Access Program (EAP) for OLZ/SAM in Pediatric Participants With Schizophrenia or Bipolar I Disorder (ALKS 3831-315) N/A To provide continued access to OLZ/SAM for pediatric participants with schi...
Show More Location
Alkermes Investigator Site
Learn More & Join Trial
A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia PHASE2 This randomized, double-blind, placebo- and active-controlled, parallel gro...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia PHASE4 This study is designed to compare the efficacy and drug tolerability of two...
Show More Location
Universitätsklinikum Aachen
Learn More & Join Trial
Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder PHASE1 To evaluate the safety, tolerability, and pharmacokinetics of olanzapine an...
Show More Location
Alkermes Investigational Site
Learn More & Join Trial
Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in Patients With Schizophrenia PHASE2 The purpose of this study is to explore the safety, tolerability, and poten...
Show More Location
Multiple Locations
Learn More & Join Trial